The mechanism of action of Cannabinoids and endocannabinoids is comparable, although not similar. Cannabinoids like THC can act positively in models of ischemic, age-related, inflammatory and autoimmune diseases, just as endocannabinoids such as PEA can. Although Cannabinoids work also via the CB 1 receptor, reason for the psychoactive high, and PEA does NOT have affinity for this receptor, reason for the lack of psychoactive side effects of PEA.
Since 2000 PEA clearly proved to be active in a wide array of pain, ischemic, age-related, inflammatory and autoimmune diseases.
1) Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia
That’s found here. Weed helps diseases from oxidizing stress (think of diseases caused by, for example, prolonged low-dose aspirin use, dementia and helps people at risk for stroke. Screw that idiot Kennedy at SAM. The government already has evidence to the contrary of that weirdo lifer Washington sylph nancy boy.
|The present invention relates to a method for promoting infant feeding, growth or development comprising administering to an infant a…|
View original post 143 more words